A detailed history of Marino, Stram & Associates LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Marino, Stram & Associates LLC holds 13,490 shares of ABBV stock, worth $2.7 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
13,490
Previous 13,587 0.71%
Holding current value
$2.7 Million
Previous $2.33 Million 14.33%
% of portfolio
0.6%
Previous 0.57%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$163.84 - $199.33 $15,892 - $19,335
-97 Reduced 0.71%
13,490 $2.66 Million
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $7,894 - $9,218
51 Added 0.38%
13,587 $2.33 Million
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $57,055 - $65,009
357 Added 2.71%
13,536 $2.46 Million
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $4,816 - $5,423
35 Added 0.27%
13,179 $2.04 Million
Q3 2023

Oct 30, 2023

SELL
$133.59 - $154.65 $11,355 - $13,145
-85 Reduced 0.64%
13,144 $1.96 Million
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $35,777 - $44,523
-270 Reduced 2.0%
13,229 $1.78 Million
Q1 2023

Apr 20, 2023

SELL
$144.61 - $166.54 $24,005 - $27,645
-166 Reduced 1.21%
13,499 $2.15 Million
Q4 2022

Jan 19, 2023

BUY
$138.31 - $165.87 $81,187 - $97,365
587 Added 4.49%
13,665 $0
Q3 2022

Oct 17, 2022

BUY
$134.21 - $153.93 $18,118 - $20,780
135 Added 1.04%
13,078 $1.76 Million
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $412 - $524
3 Added 0.02%
12,943 $1.98 Million
Q1 2022

Apr 25, 2022

BUY
$131.98 - $163.75 $29,299 - $36,352
222 Added 1.75%
12,940 $2.1 Million
Q4 2021

Jan 20, 2022

BUY
$107.43 - $135.93 $46,302 - $58,585
431 Added 3.51%
12,718 $1.72 Million
Q3 2021

Oct 14, 2021

SELL
$106.4 - $120.78 $442,624 - $502,444
-4,160 Reduced 25.29%
12,287 $1.33 Million
Q2 2021

Jul 22, 2021

BUY
$105.21 - $117.21 $596,751 - $664,815
5,672 Added 52.64%
16,447 $1.85 Million
Q1 2021

Apr 26, 2021

BUY
$102.3 - $112.62 $71,200 - $78,383
696 Added 6.91%
10,775 $1.17 Million
Q4 2020

Jan 19, 2021

BUY
$80.49 - $108.67 $14,327 - $19,343
178 Added 1.8%
10,079 $1.08 Million
Q3 2020

Oct 22, 2020

BUY
$85.91 - $100.83 $68,212 - $80,059
794 Added 8.72%
9,901 $867,000
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $145,639 - $194,887
1,985 Added 27.87%
9,107 $894,000
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $74,949 - $113,631
1,162 Added 19.5%
7,122 $543,000
Q4 2019

Jan 31, 2020

BUY
$72.13 - $90.25 $20,196 - $25,270
280 Added 4.93%
5,960 $528,000
Q3 2019

Oct 15, 2019

BUY
$62.98 - $75.72 $314 - $378
5 Added 0.09%
5,680 $430,000
Q2 2019

Jul 19, 2019

BUY
$65.7 - $83.98 $90,666 - $115,892
1,380 Added 32.13%
5,675 $413,000
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $38,801 - $45,667
503 Added 13.26%
4,295 $346,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $155 - $192
2 Added 0.05%
3,792 $380,000
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $11,913 - $13,244
-134 Reduced 3.41%
3,790 $358,000
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $21,906 - $25,920
-244 Reduced 5.85%
3,924 $364,000
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $1,840 - $2,464
-20 Reduced 0.48%
4,168 $394,000
Q4 2017

Mar 09, 2018

BUY
$89.56 - $98.21 $375,077 - $411,303
4,188
4,188 $405,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Marino, Stram & Associates LLC Portfolio

Follow Marino, Stram & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marino, Stram & Associates LLC with notifications on news.